Drugmaker Wockhardt said that the United States Food and Drug Administration (US FDA) had accepted the New Drug Application ...
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of ...
A shadow market for AI training and data labeling accounts has emerged, with scammers selling Outlier, Mercor, and Surge AI accounts online.
Wockhardt today announced that the United States Food and Drug Administration (US FDA) has formally accepted the New Drug Application (NDA) for its novel, first-in-class antibiotic Zaynich. The NDA ...
Wockhardt's shares jumped 19.3% to ₹1,473 following the US FDA's acceptance of its antibiotic drug Zaynich's New Drug ...
Approval for a tyre-fitting and vehicle servicing centre and for new digital bus shelter screens are among the latest ...
Under the proposal would see the city transfer 3.7 hectares of industrial land, almost four city block in size, in northeast ...
Stories of High-Quality Development | Yin Yanlin: Unswervingly follow the path of financial development with Chinese ...
Mumbai: Wockhardt Ltd. has announced that the United States Food and Drug Administration (US FDA) has formally accepted the ...
Ukraine’s leading digital operator, and the WINWIN AI Center of Excellence under the Ministry of Digital Transformation of ...
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, ...